|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 0.1935 SEK | -1.78% |
|
-7.86% | +7.80% |
| 08-25 | XP Chemistries AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-25 | XP Chemistries Q2 Net Sales Amounted To SEK 59,000 | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 6.27M | - | - | - | - | - |
| 994B | |||||
| 640B | - | - | - | ||
| 454B | |||||
| 337B | |||||
| 261B |
- Stock Market
- Stocks
- XPC Stock
- Charts XP Chemistries AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
